Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin
AssigneeAmicus Therapeutics, Inc.
InventorsEric Richard Sjoberg, Gary Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmicus Therapeutics, Inc.
InventorsEric Richard Sjoberg, Gary Lee
Estimating the term…
Pharmacological chaperone compounds and methods for the treatment of an individual having, or at risk of having, a disease condition associated with alpha-1-antitrypsin by using said compounds are disclosed. In particular, such methods are useful for the treatment or prevention of lung disorders associated with alpha-1-antitrypsin deficiency as well as liver disorders associated with an excess of alpha-1-antitrypsin. Suitable pharmacological chaperones include peptides and low-molecular weight compounds. Also provided is an assay for determining whether a test compound modulates alpha-1-antitrypsin activity.
A method of treating an individual having or at risk of having a disease condition associated with α-1-antitrypsin comprising administering to the individual an effective amount of a pharmacological chaperone.
A method for determining modulation of alpha-1-antitrypsin activity by a test compound comprising:
A compound according to the structure:
A compound according to the structure:
Dependencies are inferred from the claim text.